Average Co-Inventor Count = 5.37
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Inspire Pharmaceuticals, Inc. (15 from 91 patents)
2. Bristol-myers Squibb Pharma Company (3 from 234 patents)
3. Sage Therapeutics, Inc. (3 from 92 patents)
4. Merck Sharp + Dohme Corp. (1 from 2,405 patents)
5. Inspire (1 from 1 patent)
23 patents:
1. 12358942 - Crystalline 19-nor C3,3-disubstituted C21-n-pyrazolyl steroid
2. 11884696 - Crystalline 19-nor C3,3-disubstituted C21-n-pyrazolyl steroid
3. 11236121 - Crystalline 19-nor C3,3-disubstituted C21-N-pyrazolyl steroid
4. 8835457 - Bridged bicyclic RHO kinase inhibitor compounds, compositions and use
5. 8604205 - Cytoskeletal active rho kinase inhibitor compounds, composition and use
6. 8604218 - Cytoskeletal active rho kinase inhibitor compounds, composition and use
7. 8476295 - Bridged bicyclic RHO kinase inhibitor compounds, composition and use
8. 8158796 - Process for the preparation of Rho-kinase inhibitor compounds
9. 8071779 - Cytoskeletal active rho kinase inhibitor compounds, composition and use
10. 8039465 - Cytoskeletal active compounds, composition and use
11. 7947850 - Process for the preparation of 3,4-disubstituted-thiazolidin-2-ones
12. 7943760 - Non-nucleotide composition for inhibiting platelet aggregation
13. 7932376 - Pyrimidine-based non-nucleotide composition and method for inhibiting platelet aggregation
14. 7741473 - Process for the preparation of 4,6-disubstituted-tetrahydro-furo, thieno, pyrrolo and cyclopenta-[3,4][1,3]dioxoles
15. 7666861 - Cytoskeletal active compounds, composition and use